Tofaxen 5 MG (Tofacitinib)

Basic Product Information of Tofaxen (Tofacitinib) 5mg

How Tofaxen (Tofacitinib) Works

Tofaxen contains Tofacitinib, a potent, selective inhibitor of the Janus kinase (JAK) family of enzymes, preferentially inhibiting JAK1 and JAK3 with functional selectivity over JAK2. JAKs are intracellular enzymes that transmit signals from cytokine and growth factor receptors on the cell membrane, and play a key role in haematopoiesis and immune cell function.

In conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, these signalling pathways become chronically overactive, driving persistent inflammation and tissue damage. Tofacitinib modulates signalling at the point of the JAKs, preventing the phosphorylation and activation of signal transducers and activators of transcription (STATs). By interrupting this cascade, Tofaxen reduces the inflammatory signals responsible for joint pain, swelling, and bowel inflammation in these autoimmune conditions.

Unlike biologic therapies that require injection or infusion, Tofaxen is a convenient oral tablet, offering patients an effective alternative for managing chronic inflammatory disease once other standard therapies have proven inadequate.

Indications for Tofaxen (Tofacitinib)

Tofaxen (Tofacitinib) is indicated for the following conditions:

Benefits of Tofaxen (Tofacitinib) 5mg

How to Take Tofaxen (Tofacitinib)

Monitoring and Dosage Adjustments

Regular monitoring is essential during Tofaxen treatment. All patients should be screened for tuberculosis before starting, with treatment for latent TB completed first if the test is positive, and should be monitored for active TB throughout treatment regardless of initial results. Your healthcare provider will also monitor blood counts for lymphopenia, neutropenia, and anaemia, liver function tests, lipid levels, and signs of infection, blood clots, or cardiovascular symptoms. Report any fever, unusual fatigue, chest pain, sudden breathlessness, leg swelling or pain, or signs of infection to your doctor immediately.

Drug Interactions and Important Information

Avoid concomitant use of Tofaxen with biologic DMARDs, other JAK inhibitors, or potent immunosuppressants such as azathioprine and cyclosporine, as these combinations may increase the risk of serious infection and immunosuppression.

Reduce the Tofaxen dose to 5mg once daily when co-administered with strong CYP3A4 inhibitors (such as ketoconazole), or with medicines that are both moderate CYP3A4 inhibitors and strong CYP2C19 inhibitors (such as fluconazole). Avoid the use of live vaccines during treatment. Always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Tofaxen.

Side Effects and Precautions

Who Should Use Tofaxen (Tofacitinib)?

Tofaxen is suitable for adult patients diagnosed with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or moderately to severely active ulcerative colitis who have had an inadequate response to, or are intolerant of, methotrexate or other standard therapies. Given its boxed warning, current clinical guidance generally reserves JAK inhibitors such as Tofaxen for patients who have already tried a TNF-blocker therapy where appropriate. It is prescribed by rheumatologists, gastroenterologists, and specialist physicians experienced in managing autoimmune and inflammatory conditions. A thorough medical assessment including tuberculosis screening, blood counts, and cardiovascular risk evaluation is required before initiating treatment.

Manufacturer: Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in Dhaka, Bangladesh, focused on complex, technology-driven specialty medicines across oncology, immunology, hematology, and virology. Operating under Bangladesh’s TRIPS/Doha Declaration exemption for least-developed countries, Everest manufactures advanced generics such as Tofaxen under cGMP-compliant standards, with the stated mission of making high-cost, life-saving medicines accessible and affordable to patients around the world. Tofaxen is one of Everest’s specialty immunology products, offering a bioequivalent alternative to Xeljanz by Pfizer at a fraction of the cost.

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty and autoimmune medications. We ensure Tofaxen (Tofacitinib) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Tofaxen (Tofacitinib) from Mediaid Pharmacy?

Tofaxen represents a well-established, versatile option for patients managing rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis. As the generic equivalent of Xeljanz by Pfizer, it delivers the same active ingredient, Tofacitinib, with the same proven JAK-inhibition mechanism at a dramatically more affordable price. Manufactured by Everest Pharmaceuticals Ltd. under cGMP-compliant standards and distributed globally by Mediaid Pharmacy, Tofaxen gives patients worldwide access to effective autoimmune therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Tofacitinib option with worldwide delivery, Tofaxen from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Tofaxen (Tofacitinib)